Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{e2a6092076d546dcb1e45848ea177667,
title = "Danish guidelines for management of non-APC-associated hereditary polyposis syndromes",
abstract = "Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.",
keywords = "Cancer, Genetics, Guideline, Hereditary, Management, Polyposis, Surveillance",
author = "Jelsig, {Anne Marie} and Karstensen, {John G{\'a}sdal} and Niels Jespersen and Zohreh Ketabi and Charlotte Lautrup and Karina R{\o}nlund and Lone Sunde and Karin Wadt and Ole Thorlacius-Ussing and Niels Qvist",
note = "{\textcopyright} 2021. The Author(s).",
year = "2021",
month = oct,
day = "7",
doi = "10.1186/s13053-021-00197-8",
language = "English",
volume = "19",
pages = "1--9",
journal = "Hereditary Cancer in Clinical Practice",
issn = "1731-2302",
publisher = "BioMed Central Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

AU - Jelsig, Anne Marie

AU - Karstensen, John Gásdal

AU - Jespersen, Niels

AU - Ketabi, Zohreh

AU - Lautrup, Charlotte

AU - Rønlund, Karina

AU - Sunde, Lone

AU - Wadt, Karin

AU - Thorlacius-Ussing, Ole

AU - Qvist, Niels

N1 - © 2021. The Author(s).

PY - 2021/10/7

Y1 - 2021/10/7

N2 - Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.

AB - Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.

KW - Cancer

KW - Genetics

KW - Guideline

KW - Hereditary

KW - Management

KW - Polyposis

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=85116618898&partnerID=8YFLogxK

U2 - 10.1186/s13053-021-00197-8

DO - 10.1186/s13053-021-00197-8

M3 - Review

C2 - 34620187

VL - 19

SP - 1

EP - 9

JO - Hereditary Cancer in Clinical Practice

JF - Hereditary Cancer in Clinical Practice

SN - 1731-2302

IS - 1

M1 - 41

ER -

ID: 68351375